Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

     1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Offering

  2.3.2 Market Size By Technology

  2.3.3 Market Size By Application

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

3.4.1. Data & Technology Providers
3.4.2. AI Platform & Software Developers
3.4.3. Clinical Trial Service Providers
3.4.4. Pharmaceutical Companies, CROs & Research Institutes

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Clinical Trial Efficiency & Performance Metrics

  4.1.1 Average Reduction in Clinical Trial Cycle Time Using AI (%)

  4.1.2 Percentage Improvement in Patient Enrollment Speed Through AI (%)

  4.1.3 Average Reduction in Clinical Trial Costs Through AI Integration (%)

  4.1.4 Percentage Increase in Protocol Adherence with AI Monitoring (%)

  4.1.5 Average Time Saved in Data Cleaning & Lock Processes (Days)

 4.2 Patient Recruitment & Retention Statistics

  4.2.1 Percentage Improvement in Patient Matching Accuracy Using AI (%)

  4.2.2 Average Reduction in Patient Screening Failures with AI Algorithms (%)

  4.2.3 Percentage Increase in Patient Retention Rates Through AI Engagement Tools (%)

  4.2.4 Share of Trials Achieving Enrollment Targets Ahead of Schedule Using AI (%)

  4.2.5 Average Time Reduction in Site Selection & Feasibility Assessment (Weeks)

 4.3 Technology Adoption & Implementation Metrics

  4.3.1 Share of Clinical Trials Utilizing AI-Powered Data Management Systems (%)

  4.3.2 Percentage of CROs Offering AI-Integrated Clinical Trial Solutions (%)

  4.3.3 Percentage Growth in AI Adoption for Risk-Based Monitoring (%)

  4.3.4 Share of AI Platforms Utilizing Natural Language Processing for Data Extraction (%)

  4.3.5 Average Improvement in Trial Data Accuracy Through AI Algorithms (%)

 4.4 Drug Development & Outcome Optimization Indicators

  4.4.1 Percentage Improvement in Clinical Trial Success Rates Using AI (%)

  4.4.2 Average Reduction in Time-to-Market for Drugs Using AI in Trials (Months)

  4.4.3 Percentage Increase in Real-World Data Integration in Trial Designs Using AI (%)

  4.4.4 Share of AI-Driven Adaptive Trial Designs in Late-Stage Clinical Development (%)

  4.4.5 Average Improvement in Prediction of Adverse Events Using AI Models (%)

5. AI In Clinical Trials Market Segmental Analysis & Forecast, By Offering, 2022–2035, Value (USD Billion)

 5.1 Introduction
 5.2 Software
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2035
 5.3 Services

6. AI In Clinical Trials Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

 6.1 Introduction
 6.2 Machine Learning
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022–2035
 6.3 Deep Learning
 6.4 Natural Language Processing
 6.5 Computer Vision & Other Technologies

7. AI In Clinical Trials Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

 7.1 Introduction
 7.2 Patient Recruitment & Enrollment
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022–2035
 7.3 Trial Design & Protocol Optimization
 7.4 Data Management & Monitoring
 7.5 Risk-Based Monitoring & Safety Surveillance

8. AI In Clinical Trials Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

 8.1 Introduction
 8.2 Pharmaceutical & Biotechnology Companies
  8.2.1 Key Trends
  8.2.2 Market Size & Forecast, 2022–2035
 8.3 Contract Research Organizations (CROs)
 8.4 Academic & Research Institutes

9. AI In Clinical Trials Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 9.1 Introduction

 9.2 North America

  9.2.1 Key Trends

  9.2.2 AI In Clinical Trials Market Size & Forecast, By Offering, 2022–2035

  9.2.3 AI In Clinical Trials Market Size & Forecast, By Technology, 2022–2035

  9.2.4 AI In Clinical Trials Market Size & Forecast, By Application, 2022–2035

  9.2.5 AI In Clinical Trials Market Size & Forecast, By End User, 2022–2035

  9.2.6 AI In Clinical Trials Market Size & Forecast, By Country, 2022–2035

   9.2.6.1 USA

   9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 AI In Clinical Trials Market Size & Forecast, By Offering, 2022–2035

 9.3.3 AI In Clinical Trials Market Size & Forecast, By Technology, 2022–2035

 9.3.4 AI In Clinical Trials Market Size & Forecast, By Application, 2022–2035

 9.3.5 AI In Clinical Trials Market Size & Forecast, By End User, 2022–2035

 9.3.6 AI In Clinical Trials Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 AI In Clinical Trials Market Size & Forecast, By Offering, 2022–2035

 9.4.3 AI In Clinical Trials Market Size & Forecast, By Technology, 2022–2035

 9.4.4 AI In Clinical Trials Market Size & Forecast, By Application, 2022–2035

 9.4.5 AI In Clinical Trials Market Size & Forecast, By End User, 2022–2035

 9.4.6 AI In Clinical Trials Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 AI In Clinical Trials Market Size & Forecast, By Offering, 2022–2035

 9.5.3 AI In Clinical Trials Market Size & Forecast, By Technology, 2022–2035

 9.5.4 AI In Clinical Trials Market Size & Forecast, By Application, 2022–2035

 9.5.5 AI In Clinical Trials Market Size & Forecast, By End User, 2022–2035

 9.5.6 AI In Clinical Trials Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 AI In Clinical Trials Market Size & Forecast, By Offering, 2022–2035

 9.6.3 AI In Clinical Trials Market Size & Forecast, By Technology, 2022–2035

 9.6.4 AI In Clinical Trials Market Size & Forecast, By Application, 2022–2035

 9.6.5 AI In Clinical Trials Market Size & Forecast, By End User, 2022–2035

 9.6.6 AI In Clinical Trials Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

  10.6.1 IQVIA Inc.

10.6.1.1 Company Overview & Snapshot

10.6.1.2 Product/Service Portfolio

10.6.1.3 Key Company Financials

10.6.1.4 Geographical Presence

10.6.1.5 SWOT Analysis

10.6.2 Medidata Solutions, Inc. (a Dassault Systèmes company)
10.6.3 Oracle Corporation
10.6.4 ICON plc
10.6.5 Parexel International Corporation
10.6.6 Certara, Inc.
10.6.7 Saama Technologies, Inc.
10.6.8 AiCure, LLC
10.6.9 Unlearn.AI, Inc.
10.6.10 ConcertAI, LLC
10.6.11 Tempus AI, Inc.
10.6.12 Median Technologies
10.6.13 Deep 6 AI, Inc.
10.6.14 Phesi, Inc.
10.6.15 H1 Insights, Inc.
10.6.16 Formation Bio (TrialSpark)
10.6.17 Antidote Technologies Ltd.
10.6.18 Reify Health, Inc.
10.6.19 Lindus Health Ltd.
10.6.20 Suvoda LLC

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures